RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,000 | +85.2% | 26,165 | +80.6% | 0.00% | – |
| Q2 2023 | $108,000 | +103.8% | 14,489 | +83.2% | 0.00% | – |
| Q1 2023 | $53,000 | -69.2% | 7,908 | -64.7% | 0.00% | – |
| Q4 2022 | $172,000 | +719.0% | 22,409 | +1051.0% | 0.00% | – |
| Q3 2022 | $21,000 | +162.5% | 1,947 | +92.4% | 0.00% | – |
| Q2 2022 | $8,000 | -84.3% | 1,012 | -85.7% | 0.00% | – |
| Q1 2022 | $51,000 | -88.0% | 7,081 | -71.5% | 0.00% | – |
| Q4 2021 | $425,000 | +553.8% | 24,803 | +770.6% | 0.00% | – |
| Q3 2021 | $65,000 | +22.6% | 2,849 | +97.2% | 0.00% | – |
| Q2 2021 | $53,000 | – | 1,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $26,790,000 | 44.35% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $50,694,446,000 | 9.21% |
| Samsara BioCapital, LLC | 775,583 | $28,309,000 | 3.50% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $55,088,000 | 3.17% |
| Laurion Capital Management LP | 3,858,617 | $140,839,000 | 0.78% |
| Casdin Capital, LLC | 548,156 | $20,008,000 | 0.51% |
| ALLEN OPERATIONS LLC | 68,104 | $2,486,000 | 0.43% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 472,552 | $17,248,000 | 0.40% |
| Ratan Capital Management LP | 110,000 | $4,015,000 | 0.35% |
| Comprehensive Financial Management LLC | 1,109,395 | $40,493,000 | 0.34% |